🇺🇸 FDA
Patent

US 6194390

Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis

expired A61KA61K31/17A61K31/19

Quick answer

US patent 6194390 (Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/17, A61K31/19, A61K31/70, A61K31/7072